The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
119448144 11944814 4 F 201512 20160621 20160125 20160712 PER US-PFIZER INC-2016012140 PFIZER 63.00 YR F Y 92.99000 KG 20160712 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
119448144 11944814 1 PS PRISTIQ EXTENDED-RELEASE DESVENLAFAXINE SUCCINATE 1 Oral 50 MG, 1X/DAY E10582630 21992 50 MG PROLONGED-RELEASE TABLET QD
119448144 11944814 2 SS PRISTIQ EXTENDED-RELEASE DESVENLAFAXINE SUCCINATE 1 21992 PROLONGED-RELEASE TABLET
119448144 11944814 3 SS PRISTIQ EXTENDED-RELEASE DESVENLAFAXINE SUCCINATE 1 21992 PROLONGED-RELEASE TABLET
119448144 11944814 4 C INVOKANA CANAGLIFLOZIN 1 300 MG, 1X/DAY 0 300 MG QD
119448144 11944814 5 C SYNTHROID LEVOTHYROXINE SODIUM 1 0.088 UG, 1X/DAY 0 .088 UG QD
119448144 11944814 6 C SYNTHROID LEVOTHYROXINE SODIUM 1 0
119448144 11944814 7 C ZYRTEC CETIRIZINE HYDROCHLORIDE 1 10 MG, ONCE 0 10 MG
119448144 11944814 8 C ZYRTEC CETIRIZINE HYDROCHLORIDE 1 UNK 0
119448144 11944814 9 C ALDACTAZIDE HYDROCHLOROTHIAZIDESPIRONOLACTONE 1 2 DF, DAILY (25 HYDROCHLOROTHIAZIDE / 25 SPIRONOLACTONE) 0 2 DF
119448144 11944814 10 C L-THYROXINE LEVOTHYROXINE 1 0.88 (UNITS UNKNOWN), DAILY 0
119448144 11944814 11 C METFORMIN METFORMIN HYDROCHLORIDE 1 UNK 0
119448144 11944814 12 C SPIRONOLACTONE. SPIRONOLACTONE 1 UNK 0
119448144 11944814 13 C VESICARE SOLIFENACIN SUCCINATE 1 UNK 0
119448144 11944814 14 C OMEPRAZOLE. OMEPRAZOLE 1 UNK 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
119448144 11944814 1 Anger
119448144 11944814 2 Generalised anxiety disorder
119448144 11944814 3 Major depression
119448144 11944814 4 Diabetes mellitus
119448144 11944814 5 Hypothyroidism
119448144 11944814 6 Thyroidectomy
119448144 11944814 7 Hypersensitivity
119448144 11944814 8 Rhinitis allergic
119448144 11944814 11 Diabetes mellitus
119448144 11944814 12 Hypertension
119448144 11944814 14 Gastrooesophageal reflux disease

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
119448144 11944814 Anger
119448144 11944814 Anxiety
119448144 11944814 Confusional state
119448144 11944814 Depression
119448144 11944814 Feeling abnormal
119448144 11944814 Libido decreased
119448144 11944814 Malaise
119448144 11944814 Mental disorder
119448144 11944814 Nausea
119448144 11944814 Nervousness
119448144 11944814 Tearfulness

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
119448144 11944814 1 20151222 20151227 0
119448144 11944814 4 20141217 0
119448144 11944814 5 1994 0
119448144 11944814 7 2000 0
119448144 11944814 8 20140919 0
119448144 11944814 11 20141219 0
119448144 11944814 12 20140919 0
119448144 11944814 13 20151015 0
119448144 11944814 14 20150629 0